- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 14.10. | FDA approves AbbVie's Rinvoq for inflammatory bowel disease | ||
| 14.10. | CIPO grants patent to Palisade Bio's PALI-2108 | ||
| 13.10. | BIOSECURE returns to US pharma agenda with 2.0 update | ||
| 13.10. | AstraZeneca inks Trump drug pricing deal amid tariff threats | ||
| 13.10. | J&J in talks to acquire Protagonist Therapeutics | ||
| 13.10. | FDA approves Teva and Medincell's bipolar I disorder treatment | ||
| 10.10. | BMS expands CAR-T portfolio with $1.5bn Orbital buyout | ||
| 10.10. | AstraZeneca sets $4.5bn Virginia API plant construction in motion | ||
| 10.10. | Flu vaccine uptake increases 28% in England | ||
| 10.10. | FDA approves Celltrion's Eydenzelt for eye diseases | ||
| 10.10. | Turbine and AstraZeneca partner for ADC discovery | ||
| 09.10. | Boehringer's Jascayd nets first FDA IPF approval in over 10 years | ||
| 09.10. | Novo Nordisk buys MASH specialist Akero for up to $5.2bn | ||
| 09.10. | Amazon Pharmacy kiosks to provide prescription medications in minutes | ||
| 09.10. | Arthrosi gains $153m for development of gout therapy | ||
| 09.10. | FDA approves Regeneron's Libtayo for high-risk CSCC post-surgery | ||
| 08.10. | China accounts for one-fifth of global drugs in development | ||
| 08.10. | Ex-FDA chief Peter Marks joins Eli Lilly's infectious disease unit | ||
| 08.10. | MapLight's $251m IPO sees schizophrenia drug developers on top | ||
| 08.10. | Affinia raises $40m for gene therapy development | ||
| 08.10. | Oragenics partners Receptor.AI for brain health candidate portfolio | ||
| 08.10. | CDC amends Covid-19, chickenpox immunisation schedule amid vaccine controversy | ||
| 08.10. | Lilly's Omvoh benefit continues for four years in UC | ||
| 06.10. | Funds dry up for mRNA vaccines amid US political storm | ||
| 06.10. | FDA backs generics onshoring push with ANDA priority scheme |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .